<b><span style="font-family:Verdana;">INTRODUCTION</span></b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="...<b><span style="font-family:Verdana;">INTRODUCTION</span></b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">: Extracorporeal membrane oxygenation (ECMO) is commonly used for refractory cardiac or respiratory failure. There are reported cases of successful use of ECMO in patients with septic shock;however, there is a lack of evidence to prove its overall efficacy. Thus, we conducted this study to analyze the relationship between sepsis and ECMO in our own patients.</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">METHODS</span></b></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">: 305 patients who were placed on ECMO between 2010 and 2020 were identified within an IRB-approved database. Their clinical outcomes were an</span><span><span style="font-family:Verdana;">alyzed with a specific focus on patients who were septic before or during ECMO, defined as a positive blood culture. Group S was composed of patients with a positive blood culture before or during ECMO, while Group N was composed of all patients without a positive blood culture before or during ECMO. The primary outcome compared between groups was </span><span style="font-family:Verdana;">ECMO</span><span style="font-family:Verdana;"> survival rate. </span><b><span style="font-family:Verdana;">RESULTS</span></b><span style="font-family:Verdana;">: Among the 305 patients on ECMO, 58 (19%) were in Group S and 247 (81%) were in Group N. ECMO survival rates were 45% in Group S and 62% in Group N (p = 0.017).</span></span></span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">CONCLUSION</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana展开更多
文摘<b><span style="font-family:Verdana;">INTRODUCTION</span></b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">: Extracorporeal membrane oxygenation (ECMO) is commonly used for refractory cardiac or respiratory failure. There are reported cases of successful use of ECMO in patients with septic shock;however, there is a lack of evidence to prove its overall efficacy. Thus, we conducted this study to analyze the relationship between sepsis and ECMO in our own patients.</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">METHODS</span></b></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">: 305 patients who were placed on ECMO between 2010 and 2020 were identified within an IRB-approved database. Their clinical outcomes were an</span><span><span style="font-family:Verdana;">alyzed with a specific focus on patients who were septic before or during ECMO, defined as a positive blood culture. Group S was composed of patients with a positive blood culture before or during ECMO, while Group N was composed of all patients without a positive blood culture before or during ECMO. The primary outcome compared between groups was </span><span style="font-family:Verdana;">ECMO</span><span style="font-family:Verdana;"> survival rate. </span><b><span style="font-family:Verdana;">RESULTS</span></b><span style="font-family:Verdana;">: Among the 305 patients on ECMO, 58 (19%) were in Group S and 247 (81%) were in Group N. ECMO survival rates were 45% in Group S and 62% in Group N (p = 0.017).</span></span></span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">CONCLUSION</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana
